Description
Recombinant monoclonal antibody to TL1A. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma TAN2-2. This chimeric mouse antibody was made using the variable domain sequences of the original Rat IgG format, for improved compatibility with existing reagents, assays and techniques.
Target
TL1A
Target Alias Names
Tnfsf15, bM20K13.3 (tumor necrosis factor (ligand) superfamily, member 15), MGC129934, MGC129935, TL1, TNF ligand-related molecule 1, TNF superfamily ligand TL1A, tumor necrosis factor (ligand) superfamily member 15, tumor necrosis factor (ligand) superfamily, member 15, tumor necrosis factor ligand 1B, Tumor necrosis factor ligand superfamily member 15, Vascular endothelial cell growth inhibitor, vascular endothelial growth inhibitor, vascular endothelial growth inhibitor-192A, VEGI, VEGI192A
Isotype/Mimetic
IgG2a
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression